Ganghua Lu

Notable Publications:

i. Lu G, Gao D, Jiang W, et al. Disrupted gut microecology after high‑dose 131I therapy and radioprotective effects of arachidonic acid supplementation. Eur J Nucl Med Mol Imaging. (IF=9.1, Q1)

ii. Lu G, Gao D, Liu Y, et al. Early and long-term responses of intestinal microbiota and metabolites to 131I treatment in differentiated thyroid cancer patients. BMC Med. (IF=9.3, Q1)

iii. Lu G, Yu X, Jiang W, et al. Alterations of Gut Microbiome and Metabolite Profiles Associated with Anabatic Lipid Dysmetabolism in Thyroid Cancer. Front Endocrinol. (IF=6.1, Q1)

iv. Lu GH, Gong SG, Li C, et al. Prognostic Value of Gamma-Glutamyltransferase in Male Patients with Idiopathic Pulmonary Arterial Hypertension. Front Cardiovasc Med. (IF=3.9, Q2)

v. Jiang W, Lu G, Qiao T, et al. Integrated microbiome and metabolome analysis reveals a distinct microbial and metabolic signature in Graves' disease and hypothyroidism. Heliyon. (IF=4.0, Q2)

vi. Gao D, Xiang Q, Lu G, et al. Evaluation and Analysis of Anxiety and Depression Symptoms for College Students during COVID-19 Pandemic. BMC Psychol. (IF=2.6, 共一, Q2)

vii. Liu X, Jiang W, Lu G, et al.The Potential Role of Pyrroloquinoline Quinone to Regulate Thyroid Function and Gut Microbiota Composition of Graves' Disease in Mice. Pol J Microbiol. (IF=2.1, Q4)

viii. Liu Y, Lu G, Gao D, et al. A novel prognostic model for ovarian cancer based on Nectin family and Necl-like molecules: Nectin Family Prognostic Model in Ovarian Cancer. Cell Mol Biol. (IF=1.6, Q4)